Ken Cacciatore
Stock Analyst at TD Cowen
(0)
# 5036
Out of 5,370 analysts
17
Total ratings
30.00%
Success rate
-29.38%
Average return
Main Sectors:
Name | Action | PT | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
ARQT Arcutis Biotherapeut... | Maintains: Outperform | 65 50 | 13.1 | 281.68% | 2 | Aug 9, 2023 | |
BHC Bausch Health Compan... | Downgrades: Market Perform | n/a | n/a | n/a | 1 | Jun 16, 2023 | |
TAK Takeda Pharmaceutica... | Maintains: Outperform | 30 20 | 14.96 | 33.69% | 4 | May 16, 2023 | |
ISEE IVERIC bio | Downgrades: Market Perform | n/a | n/a | n/a | 2 | May 8, 2023 | |
SCPH scPharmaceuticals | Initiates Coverage On: Outperform | 25 | 3.99 | 526.57% | 1 | Dec 1, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 35 | 12.07 | 189.98% | 1 | May 11, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 50 | 4.14 | 1107.73% | 1 | Jul 13, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 50 | 3.16 | 1482.28% | 1 | Oct 19, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 45 | 15.01 | 199.8% | 1 | Apr 17, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 460 | 13.77 | 3240.6% | 1 | Mar 2, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Outperform | 375 | n/a | n/a | 1 | Dec 18, 2019 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Market Perform | n/a | n/a | n/a | 1 | Sep 22, 2017 |